Predicting environmental chemical factors associated with disease-related gene expression data

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Patel, Chirag J ^a,b   Butte, Atul J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; PHENOL DERIVATIVE;

ACCURACY; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CELL LINE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DATABASE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG CANCER; MICROARRAY ANALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; SCREENING TEST; VALIDATION PROCESS; BREAST TUMOR; CLUSTER ANALYSIS; DANGEROUS GOODS; FACTUAL DATABASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MALE; METABOLISM; NEOPLASM; PROSTATE TUMOR; TOXICOGENETICS;

BREAST NEOPLASMS; CLUSTER ANALYSIS; DATABASES, FACTUAL; ENVIRONMENTAL EXPOSURE; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HAZARDOUS SUBSTANCES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; PHENOLS; PROSTATIC NEOPLASMS; TOXICOGENETICS;

EID: 77951840730     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-17     Document Type: Article

References (80)

1. Medicine. Environmental biology and human disease. D Schwartz F Collins, Science 2007 316 5825 695 696 17478705
2. Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks. AP Davis CG Murphy CA Saraceni-Richards MC Rosenstein TC Wiegers CJ Mattingly, Nucleic Acids Res 2009 37 Database 786 792 18782832
3. NCBI GEO: mining tens of millions of expression profiles - database and tools update. T Barrett DB Troup SE Wilhite P Ledoux D Rudnev C Evangelista IF Kim A Soboleva M Tomashevsky R Edgar, Nucleic Acids Res 2007 35 Database 760 765 17099226
4. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. AS Andrew DA Jewell RA Mason ML Whitfield JH Moore MR Karagas, Environ Health Perspect 2008 116 4 524 531 18414638
5. Global gene expression profiling in human lung cells exposed to cobalt. V Malard F Berenguer O Prat S Ruat G Steinmetz E Quemeneur, BMC Genomics 2007 8 147 17553155
6. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. W Wang Y Li Y Li A Hong J Wang B Lin R Li, Int J Cancer 2009 124 3 521 530 18975380
7. One-month diesel exhaust inhalation produces hypertensive gene expression pattern in healthy rats. RR Gottipolu JG Wallenborn ED Karoly MC Schladweiler AD Ledbetter T Krantz WP Linak A Nyska JA Johnson R Thomas, et al. Environ Health Perspect 2009 117 1 38 46 19165385
8. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. J Lamb ED Crawford D Peck JW Modell IC Blat MJ Wrobel J Lerner JP Brunet A Subramanian KN Ross, et al. Science 2006 313 5795 1929 1935 17008526
9. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. AH Bild G Yao JT Chang Q Wang A Potti D Chasse MB Joshi D Harpole JM Lancaster A Berchuck, et al. Nature 2006 439 7074 353 357 16273092
10. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. M Ashburner CA Ball JA Blake D Botstein H Butler JM Cherry AP Davis K Dolinski SS Dwight JT Eppig, et al. Nat Genet 2000 25 1 25 29 10802651
11. Genetic and environmental pathways to complex diseases. JM Gohlke R Thomas Y Zhang MC Rosenstein AP Davis C Murphy KG Becker CJ Mattingly CJ Portier, BMC Syst Biol 2009 3 46 19416532
12. The genetic association database. KG Becker KC Barnes TJ Bright SA Wang, Nat Genet 2004 36 5 431 432 15118671
13. The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. CJ Mattingly MC Rosenstein AP Davis GT Colby JN Forrest JL Boyer, Toxicol Sci 2006 92 2 587 595 16675512
14. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proc Natl Acad Sci USA 2001 98 9 5116 5121 11309499
15. Homologene. http://www.ncbi.nlm.nih.gov/homologene
16. High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BR Zeeberg H Qin S Narasimhan M Sunshine H Cao DW Kane M Reimers RM Stephens D Bryant SK Burt, et al. BMC Bioinformatics 2005 6 168 15998470
17. R: A language and enviornment for statistical computing. R Core Team, 2.8.0 edn Vienna, Austria: R Foundation for Statistical Computing 2008
18. 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Y Bossé K Maghni TJ Hudson, Physiol Genomics 2007 29 2 161 168 17213369
19. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. N Tijet PC Boutros ID Moffat AB Okey J Tuomisto R Pohjanvirta, Mol Pharmacol 2006 69 1 140 153 16214954
20. Discrimination of vanadium from zinc using gene profiling in human bronchial epithelial cells. Z Li J Stonehuerner RB Devlin YC Huang, Environ Health Perspect 2005 113 1747 1754 16330358
21. Gene expression profiling of 17beta-estradiol and genistein effects on mouse thymus. V Selvaraj D Bunick C Finnigan-Bunick RW Johnson H Wang L Liu PS Cooke, Toxicol Sci 2005 87 1 97 112 15947025
22. Whole-genome cartography of estrogen receptor alpha binding sites. CY Lin VB Vega JS Thomsen T Zhang SL Kong M Xie KP Chiu L Lipovich DH Barnett F Stossi, et al. PLoS Genet 2007 3 6 87 17542648
23. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. UR Chandran C Ma R Dhir M Bisceglia M Lyons-Weiler W Liang G Michalopoulos M Becich FA Monzon, BMC Cancer 2007 7 64 17430594
24. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. YP Yu D Landsittel L Jing J Nelson B Ren L Liu C McDonald R Thomas R Dhir S Finkelstein, et al. J Clin Oncol 2004 22 14 2790 2799 15254046
25. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. MT Landi T Dracheva M Rotunno JD Figueroa H Liu A Dasgupta FE Mann J Fukuoka M Hames AW Bergen, et al. PLoS ONE 2008 3 2 1651 18297132
26. The prognostic role of a gene signature from tumorigenic breast-cancer cells. R Liu X Wang GY Chen P Dalerba A Gurney T Hoey G Sherlock J Lewicki K Shedden MF Clarke, N Engl J Med 2007 356 3 217 226 17229949
27. PubChem: a public information system for analyzing bioactivities of small molecules. Y Wang J Xiao TO Suzek J Zhang J Wang SH Bryant, Nucleic Acids Res 2009 37 Web Server 623 633 19498078
28. An overview of the PubChem BioAssay resource. Y Wang E Bolton S Dracheva K Karapetyan BA Shoemaker TO Suzek J Wang J Xiao J Zhang SH Bryant, Nucleic Acids Res 2010 38 Database 255 266 19933261
29. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. T Uehara M Hirode A Ono N Kiyosawa K Omura T Shimizu Y Mizukawa T Miyagishima T Nagao T Urushidani, Toxicology 2008 250 1 15 26 18619722
30. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. L Benbrahim-Tallaa RA Waterland M Styblo WE Achanzar MM Webber MP Waalkes, Toxicol Appl Pharmacol 2005 206 3 288 298 16039940
31. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency. N Zanesi R Mancini C Sevignani A Vecchione M Kaou M Valtieri GA Calin Y Pekarsky JR Gnarra CM Croce, et al. Cancer Res 2005 65 15 6576 6582 16061637
32. Estrogen carcinogenesis in breast cancer. JD Yager NE Davidson, N Engl J Med 2006 354 3 270 282 16421368
33. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. SH Dairkee J Seok S Champion A Sayeed M Mindrinos W Xiao RW Davis WH Goodson, Cancer Res 2008 68 7 2076 2080 18381411
34. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. H Buteau-Lozano G Velasco M Cristofari P Balaguer M Perrot-Applanat, J Endocrinol 2008 196 2 399 412 18252963
35. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. A Subramanian P Tamayo VK Mootha S Mukherjee BL Ebert MA Gillette A Paulovich SL Pomeroy TR Golub ES Lander, et al. Proc Natl Acad Sci USA 2005 102 43 15545 15550 16199517
36. Toxicity Testing in the 21st Century: A Vision and a Strategy. Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council, Washington, D.C.: National Academies Press 2007
37. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. SM Ho WY Tang J Belmonte de Frausto GS Prins, Cancer Res 2006 66 11 5624 5632 16740699
38. Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial. RL Shazer A Jain AV Galkin N Cinman KN Nguyen RB Natale M Gross L Green LI Bender S Holden, et al. BJU Int 2006 97 4 691 697 16536755
39. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer. MT Bertilaccio M Grioni BW Sutherland E Degl'Innocenti M Freschi E Jachetti NM Greenberg A Corti M Bellone, Prostate 2008 68 10 1105 1115 18437689
40. Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer. LS Borden Jr PE Clark J Lovato MC Hall D Stindt M Harmon MM R FM Torti, Cancer 2006 107 5 1093 1100 16888761
41. A phase I study of paclitaxel/doxorubicin/thalidomide in patients with androgen- independent prostate cancer. RJ Amato H Sarao, Clin Genitourin Cancer 2006 4 4 281 286 16729912
42. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. J Kang J Bu Y Hao F Chen, Prostate Cancer Prostatic Dis 2005 8 3 274 279 15897917
43. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells. L Benbrahim-Tallaa J Liu MM Webber MP Waalkes, Prostate 2007 67 2 135 145 17075824
44. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells. M Raschke K Wahala BL Pool-Zobel, Br J Nutr 2006 96 3 426 434 16925846
45. Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: identification of novel targets. Y Takahashi JA Lavigne SD Hursting GV Chandramouli SN Perkins JC Barrett TT Wang, Mol Carcinog 2004 41 2 108 119 15378649
46. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Y Li M Che S Bhagat KL Ellis O Kucuk DR Doerge J Abrams ML Cher FH Sarkar, Neoplasia 2004 6 4 354 363 15256057
47. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer. H Koike K Ito Y Takezawa T Oyama H Yamanaka K Suzuki, Br J Cancer 2005 92 8 1538 1544 15846301
48. The evolving role of estrogen therapy in prostate cancer. WK Oh, Clin Prostate Cancer 2002 1 2 81 89 15046698
49. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer. EJ Tokar BB Ancrile RJ Ablin MM Webber, J Exp Ther Oncol 2006 5 4 323 333 17024972
50. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. LC Costello RB Franklin, Mol Cancer 2006 5 17 16700911
51. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. RG Uzzo PL Crispen K Golovine P Makhov EM Horwitz VM Kolenko, Carcinogenesis 2006 27 10 1980 1990 16606632
52. Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. IP Michael G Pampalakis SD Mikolajczyk J Malm G Sotiropoulou EP Diamandis, J Biol Chem 2006 281 18 12743 12750 16517595
53. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. RG Uzzo P Leavis W Hatch VL Gabai N Dulin N Zvartau VM Kolenko, Clin Cancer Res 2002 8 11 3579 3583 12429649
54. Transforming growth factor beta-1 enhances cytotoxic effect of doxorubicin in human lung adenocarcinoma cells of A549 line. Y Filyak O Filyak R Stoika, Cell Biol Int 2007 31 8 851 855 17418594
55. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. J Shen J Liu Y Xie BA Diwan MP Waalkes, Toxicol Sci 2007 95 2 313 320 17077188
56. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. MP Waalkes J Liu JM Ward BA Diwan, Toxicol Appl Pharmacol 2006 215 3 295 305 16712894
57. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. MP Waalkes J Liu JM Ward BA Diwan, Toxicol Appl Pharmacol 2004 198 3 377 384 15276417
58. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. TR Devereux W Holliday C Anna N Ress J Roycroft RC Sills, Carcinogenesis 2002 23 10 1737 1743 12376484
59. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin. MJ Diament GD Peluffo I Stillitani LC Cerchietti A Navigante SM Ranuncolo SM Klein, Cancer Invest 2006 24 2 126 131 16537180
60. Indomethacin reduces lung adenoma number in A/J mice. TW Moody J Leyton H Zakowicz T Hida Y Kang S Jakowlew L You L Ozbun H Zia J Youngberg, et al. Anticancer Res 2001 21 3B 1749 1755 11497255
61. Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastases. G Levin N Kariv E Khomiak A Raz, Chemotherapy 2000 46 6 429 437 11053908
62. Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions. LB Meira AM Reis DL Cheo D Nahari DK Burns EC Friedberg, Mutat Res 2001 477 1-2 51 58 11376686
63. Chrysotile-induced cell transformation and transcriptional changes of c-myc oncogene in human embryo lung cells. JG Fan QE Wang SJ Liu, Biomed Environ Sci 2000 13 3 163 169 11198217
64. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75. A Carvajal N Espinoza S Kato M Pinto A Sadarangani C Monso E Aranda M Villalon JK Richer KB Horwitz, et al. Breast Cancer Res Treat 2005 94 2 171 183 16175315
65. Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1. S Kato M Pinto A Carvajal N Espinoza C Monso A Sadarangani M Villalon JJ Brosens JO White JK Richer, et al. J Clin Endocrinol Metab 2005 90 2 1181 1188 15562024
66. Plasma phytoestrogens and subsequent breast cancer risk. M Verheus CH van Gils L Keinan-Boker PB Grace SA Bingham PH Peeters, J Clin Oncol 2007 25 6 648 655 17200150
67. Estrogen dependent growth inhibitory effects of tamoxifen but not genistein in solid tumors derived from estrogen receptor positive (ER+) primary breast carcinoma MCF7: single agent and novel combined treatment approaches. GS Nobert MM Kraak S Crawford, Bull Cancer 2006 93 7 59 66 16873071
68. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. HS Seo DG DeNardo Y Jacquot I Laios DS Vidal CR Zambrana G Leclercq PH Brown, Breast Cancer Res Treat 2006 99 2 121 134 16541309
69. Hormonal prevention of breast cancer: significance of promotional environment. R Lakshmanaswamy RC Guzman S Nandi, Adv Exp Med Biol 2008 617 469 475 18497071
70. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. M Bergman Jungestrom LU Thompson C Dabrosin, Clin Cancer Res 2007 13 3 1061 1067 17289903
71. Recent results from clinical trials using SERMs to reduce the risk of breast cancer. VG Vogel, Ann N Y Acad Sci 2006 1089 127 142 17261762
72. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. AH Eliassen SA Missmer SS Tworoger D Spiegelman RL Barbieri M Dowsett SE Hankinson, J Natl Cancer Inst 2006 98 19 1406 1415 17018787 (Pubitemid 44530717)
73. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Russo M Hasan Lareef G Balogh S Guo IH Russo, J Steroid Biochem Mol Biol 2003 87 1 1 25 14630087
74. Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. E Ackerstaff B Gimi D Artemov ZM Bhujwalla, Neoplasia 2007 9 3 222 235 17401462
75. Diallyl sulfide induces the expression of estrogen metabolizing genes in the presence and/or absence of diethylstilbestrol in the breast of female ACI rats. M Green O Newell A Aboyade-Cole S Darling-Reed RD Thomas, Toxicol Lett 2007 168 1 7 12 17129689
76. Synthesis and biological evaluation of stilbene-based pure estrogen antagonists. G Walter R Liebl E von Angerer, Bioorg Med Chem Lett 2004 14 18 4659 4663 15324884
77. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. F Vegran R Boidot C Oudin JM Riedinger F Bonnetain S Lizard-Nacol, Clin Cancer Res 2006 12 19 5794 5800 17020986
78. Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial. M Untch H Eidtmann A du Bois HG Meerpohl C Thomssen A Ebert N Harbeck C Jackisch V Heilman G Emons, et al. Eur J Cancer 2004 40 7 988 997 15093573
79. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. JP Machiels RT Reilly LA Emens AM Ercolini RY Lei D Weintraub FI Okoye EM Jaffee, Cancer Res 2001 61 9 3689 3697 11325840
80. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. TJ Murray MV Maffini AA Ucci C Sonnenschein AM Soto, Reprod Toxicol 2007 23 3 383 390 17123778